Hospital outcomes of transcatheter versus surgical aortic valve replacement in female in the United States

Hospital outcomes of transcatheter versus surgical aortic valve replacement in female in the... INTRODUCTIONFemale sex is considered as one of the risk factors for worse outcomes in cardiac surgery as represented by increased mortality in the European System for Cardiac Operative Risk Evaluation II and Society of Thoracic Surgeons score. The outcomes of female vs. male in both transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) have been controversial. In one study, female patients received more blood transfusions and had significantly higher 30‐days mortality (3.7% vs. 2.2%) compared to male who underwent SAVR . Conversely, female patients had similar or even lower early (in‐hospital or 30‐days) mortality compared to male who underwent TAVR despite experiencing more vascular complication, bleeding and stroke compared to their male counterpart .Although outcomes of females vs. males in either TAVR or SAVR have been investigated, the comparative outcomes of TAVR vs. SAVR in large female population are limited. Female exhibit different perioperative complication pattern compared to male and therefore, the optimal modes of aortic valve replacement in female patients remain undetermined. To investigate therapeutic options between TAVR and SAVR in this specific cohort, we decided to investigate the clinical outcomes between TAVR and SAVR in female using the Nationwide Inpatient Sample (NIS) database.METHODSData sourceNIS http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Catheterization and Cardiovascular Interventions Wiley

Hospital outcomes of transcatheter versus surgical aortic valve replacement in female in the United States

Loading next page...
 
/lp/wiley/hospital-outcomes-of-transcatheter-versus-surgical-aortic-valve-iqFpQDlv4j
Publisher
Wiley
Copyright
© 2018 Wiley Periodicals, Inc.
ISSN
1522-1946
eISSN
1522-726X
D.O.I.
10.1002/ccd.27362
Publisher site
See Article on Publisher Site

Abstract

INTRODUCTIONFemale sex is considered as one of the risk factors for worse outcomes in cardiac surgery as represented by increased mortality in the European System for Cardiac Operative Risk Evaluation II and Society of Thoracic Surgeons score. The outcomes of female vs. male in both transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) have been controversial. In one study, female patients received more blood transfusions and had significantly higher 30‐days mortality (3.7% vs. 2.2%) compared to male who underwent SAVR . Conversely, female patients had similar or even lower early (in‐hospital or 30‐days) mortality compared to male who underwent TAVR despite experiencing more vascular complication, bleeding and stroke compared to their male counterpart .Although outcomes of females vs. males in either TAVR or SAVR have been investigated, the comparative outcomes of TAVR vs. SAVR in large female population are limited. Female exhibit different perioperative complication pattern compared to male and therefore, the optimal modes of aortic valve replacement in female patients remain undetermined. To investigate therapeutic options between TAVR and SAVR in this specific cohort, we decided to investigate the clinical outcomes between TAVR and SAVR in female using the Nationwide Inpatient Sample (NIS) database.METHODSData sourceNIS

Journal

Catheterization and Cardiovascular InterventionsWiley

Published: Jan 1, 2018

Keywords: ; ; ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off